e-Edition
Obituaries
Special Sections
Special Occasions
Contact

Subscribe
Paywall Login
Login to Comment
Register

December 11th, 2017

jobs

homes

Home
News
Sports
Business
Entertainment
Classifieds
Commentary

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Viking Therapeutics, Inc. - Common Stock (NQ:VKTX)

35.18 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EST, Dec 31, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Viking Therapeutics, Inc. - Common Stock

< Previous 1 2

...

23 24 25 26 27 28 29 30 Next >

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

December 19, 2022

Via Benzinga

My 3 Top Biotech Stock Picks for 2023 ↗

November 22, 2022

Biotech stocks are set to shine in 2023.

Via The Motley Fool

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

November 16, 2022

Via Benzinga

Recap: Viking Therapeutics Q3 Earnings ↗

October 26, 2022

Viking Therapeutics (NASDAQ:VKTX) reported its Q3 earnings results on Wednesday, October 26, 2022 at 04:05 PM. Here's what investors need to know about the announcement.

Via Benzinga

Earnings Outlook For Viking Therapeutics ↗

October 25, 2022

Viking Therapeutics (NASDAQ:VKTX) is set to give its latest quarterly earnings report on Wednesday, 2022-10-26. Here's what investors need to know before the announcement. Analysts estimate that Viking...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

October 11, 2022

Gainers

Via Benzinga

Recap: Viking Therapeutics Q2 Earnings ↗

July 27, 2022

Viking Therapeutics (NASDAQ:VKTX) reported its Q2 earnings results on Wednesday, July 27, 2022 at 04:00 PM. Here's what investors need to know about the announcement.

Via Benzinga

FDA Lifts Clinical Hold On Viking Therapeutics' Rare Metabolic Disorder Study ↗

July 19, 2022

Via Benzinga

Earnings Scheduled For October 26, 2022 ↗

October 26, 2022

Companies Reporting Before The Bell • LG Display Co (NYSE:LPL) is projected to report quarterly loss at $0.41 per share on revenue of $4.90 billion.

Via Benzinga

Daily Biotech Pulse: Teva's Opioids Settlement, Criminal Investigation Against Cassava, Durable Responses For IN8bio's Leukemia Therapy ↗

July 27, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

April 26, 2022

During Tuesday, 581 stocks hit new 52-week lows. Interesting Highlights From Today's 52-Week Lows Meta Platforms (NASDAQ:FB) was the biggest company on a market cap basis to set a new 52-week low.

Via Benzinga

Viking Therapeutics: Q4 Earnings Insights ↗

February 09, 2022

Viking Therapeutics (NASDAQ:VKTX) reported its Q4 earnings results on Wednesday, February 9, 2022 at 04:00 PM. Here's what investors need to know about the announcement.

Via Benzinga

Earnings Scheduled For July 27, 2022 ↗

July 27, 2022

Companies Reporting Before The Bell • Equinor (NYSE:EQNR) is projected to report earnings for its second quarter.

Via Benzinga

Viking Therapeutics Earnings Preview ↗

July 26, 2022

Viking Therapeutics (NASDAQ:VKTX) is set to give its latest quarterly earnings report on Wednesday, 2022-07-27. Here's what investors need to know before the announcement. Analysts estimate that Viking...

Via Benzinga

Recap of Tuesday's Biotech Catalysts - End Of The Day Summary ↗

July 19, 2022

The U.S. Food and Drug Administration (FDA) has granted tentative approval to Avadel Pharmaceuticals’ (NASDAQ: AVDL) lead candidate LUMRYZ (FT218) for the treatment of excessive daytime sleepiness...

Via Benzinga

U.S. FDA Lifts Clinical Hold On Viking Therapeutics' Initial-Stage Genetic Disorder Study ↗

July 19, 2022

Viking Therapeutics (NASDAQ: VKTX) announced that the U.S. Food and Drug Administration (FDA) has lifted the clinical hold placed on the clinical trial of VK0214 in patients with X-linked...

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

July 08, 2022

Gainers Passage Bio (NASDAQ:PASG) shares moved upwards by 7.7% to $2.66 during Friday's after-market session. The market value of their outstanding shares is at $144.4 million.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

June 14, 2022

Gainers

Via Benzinga

Stocks That Hit 52-Week Lows On Monday ↗

June 13, 2022

During Monday's trading, 1214 companies set new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Thursday ↗

June 02, 2022

During the Thursday's session, 100 stocks hit new 52-week lows.

Via Benzinga

Insiders Buy More Than $50M Of 3 Penny Stocks ↗

May 04, 2022

Gold futures traded lower on Wednesday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around the...

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

May 24, 2022

On Tuesday, 540 companies set new 52-week lows.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

April 27, 2022

Gainers Unicycive Therapeutics (NASDAQ:UNCY) shares moved upwards by 9.9% to $1.0 during Wednesday's after-market session. The company's market cap stands at $15.0 million.

Via Benzinga

The Daily Biotech Pulse: Molecular Partners Plunges On Double Bad News, Pfizer/BioNTech Seek Nod For COVID-19 Shot In Kids, Pfizer Invests In Zentalis ↗

April 27, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours.

Via Benzinga

Viking Therapeutics Earnings Preview ↗

April 26, 2022

Viking Therapeutics (NASDAQ:VKTX) is set to give its latest quarterly earnings report on Wednesday, 2022-04-27. Here's what investors need to know before the announcement. Analysts estimate that Viking...

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

February 11, 2022

Gainers Dermata Therapeutics (NASDAQ:DRMA) shares moved upwards by 26.6% to $1.35 during Friday's regular session. As of 12:30 EST, Dermata Therapeutics's stock is...

Via Benzinga

The Daily Biotech Pulse: AstraZeneca Q4 Gets COVID Boost, Seagen Plunges On Earnings, Adcom Test Awaits Lilly ↗

February 10, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Earnings Scheduled For April 27, 2022 ↗

April 27, 2022

Companies Reporting Before The Bell • Deutsche Bank (NYSE:DB) is projected to report earnings for its first quarter.

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

April 19, 2022

On Tuesday, 242 companies hit new 52-week lows. Noteworthy Mentions In Today's 52-Week Lows: The largest company in terms of market cap to set a new 52-week low was...

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

March 15, 2022

During Tuesday's session, 454 stocks hit new 52-week lows. Intriguing Points From Today's 52-Week Lows: Taiwan Semiconductor (NYSE:TSM) was the largest company by...

Via Benzinga

< Previous 1 2

...

23 24 25 26 27 28 29 30 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

More ways to get to us

Facebook

Twitter

YouTube

ePaper Login
Subscribe
Subscription Services
Archive

About Us

The Lethbridge Herald
Other Publications
Food For Thought

Contact
Careers

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

Advertising
Terms and Conditions & Privacy Policy